9 LEGENDS
TABLE 1 Clinical and laboratory profile of the cohort
TABLE 2 Three-year EFS and OS based on Tumor Necrosis (TN) cut-offs of 100%, 90% and 70%
TABLE 3 Predictive value of clinical and laboratory parameters for Tumor Necrosis (TN)
Figure 1. Consort diagram of this retrospective study
Figure 2. A) EFS and OS of the whole cohort B) EFS and OS of localized and metastatic disease C) EFS of whole cohort based on 100% Tumor Necrosis (TN), 90%TN, 70%TN D) OS of whole cohort based on 100% TN, 90%TN, 70%TN E) EFS of localized cohort based on 100% TN, 90%TN, 70%TN F) OS of localized cohort based on 100% TN, 90%TN, 70%TN G) EFS of metastatic cohort based on 100% TN, 90%TN, 70%TN H) OS of metastatic cohort based on 100% TN, 90%TN, 70%TN
Figure 3. Survival based on tumor necrosis (TN) cut-off derived using Receiver Operating Characteristic (ROC) curve for A) EFS of the whole cohort B) OS of the whole cohort C) EFS of the localized cohort D) OS of the localized cohort E) EFS of the metastatic cohort F) OS of the metastatic cohort